BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25188646)

  • 1. Etanercept-induced sarcoidosis in rheumatoid arthritis: FDG PET findings.
    Nakajima R; Abe K; Nakajima A; Nishikawa T; Sakai S
    Clin Nucl Med; 2015 Jan; 40(1):58-61. PubMed ID: 25188646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of sarcoidosis during etanercept therapy.
    Ishiguro T; Takayanagi N; Kurashima K; Matsushita A; Harasawa K; Yoneda K; Tsuchiya N; Miyahara Y; Yamaguchi S; Yano R; Tokunaga D; Saito H; Ubukata M; Yanagisawa T; Sugita Y; Kawabata Y
    Intern Med; 2008; 47(11):1021-5. PubMed ID: 18520114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncaseating granulomas in lung: think beyond sarcoidosis.
    Khurana AK
    Chest; 2010 Jun; 137(6):1486; author reply 1486-7. PubMed ID: 20525666
    [No Abstract]   [Full Text] [Related]  

  • 4. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.
    Gifre L; Ruiz-Esquide V; Xaubet A; Gómez-Puerta JA; Hernández MV; Sanmartí R
    Arch Bronconeumol; 2011 Apr; 47(4):208-12. PubMed ID: 20638761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab.
    Burns AM; Green PJ; Pasternak S
    J Cutan Pathol; 2012 Feb; 39(2):289-93. PubMed ID: 21899592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of sarcoidosis 6-month post discontinuation of etanercept: coincidence or real association?
    Haroon M; Ryan JG; Harney S
    Clin Rheumatol; 2011 Aug; 30(8):1095-8. PubMed ID: 21380931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients.
    Verschueren K; Van Essche E; Verschueren P; Taelman V; Westhovens R
    Clin Rheumatol; 2007 Nov; 26(11):1969-71. PubMed ID: 17340045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of rheumatoid arthritis with etanercept].
    Lamprecht P; Nitschmann S
    Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
    [No Abstract]   [Full Text] [Related]  

  • 9. Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis.
    Duffy TN; Genta M; Moll S; Martin PY; Gabay C
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S106. PubMed ID: 16859610
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab.
    Honda H; Kida H; Yoshida M; Tomita T; Fujii M; Ihara S; Goya S; Tachibana I; Kawase I
    Mod Rheumatol; 2011 Dec; 21(6):660-4. PubMed ID: 21472474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrupt development of sarcoidosis with a prodromal increase in plasma osteopontin in a patient with rheumatoid arthritis during treatment with etanercept.
    Takatori S; Kamata Y; Murosaki T; Iwamoto M; Minota S
    J Rheumatol; 2010 Jan; 37(1):210-1. PubMed ID: 20040649
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of rheumatoid arthritis with etanercept.
    Genovese MC; Kremer JM
    Rheum Dis Clin North Am; 2004 May; 30(2):311-28, vi-vii. PubMed ID: 15172043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy.
    Vigne C; Tebib JG; Pacheco Y; Coury F
    Joint Bone Spine; 2013 Jan; 80(1):104-7. PubMed ID: 22885144
    [No Abstract]   [Full Text] [Related]  

  • 14. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT.
    Okamura K; Yonemoto Y; Arisaka Y; Takeuchi K; Kobayashi T; Oriuchi N; Tsushima Y; Takagishi K
    Rheumatology (Oxford); 2012 Aug; 51(8):1484-91. PubMed ID: 22513145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
    Kekow J; Welte T; Kellner U; Pap T
    Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
    [No Abstract]   [Full Text] [Related]  

  • 16. [Etanercept: does it constitute a risk factor for development of cerebral venous thrombosis?].
    Usero-Ruiz M; Díaz-Sánchez M; Moniche-Álvarez F
    Rev Neurol; 2014 Mar; 58(5):239-40. PubMed ID: 24570365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etanercept for therapy of rheumatoid arthritis].
    Miyasaka N
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():521-5. PubMed ID: 15799411
    [No Abstract]   [Full Text] [Related]  

  • 18. [Safety and Efficacy of Etanercept in Rheumatoid Arthritis With End-stage Chronic Renal Failure].
    Mahmoud I; Gafsi L; Tekaya R; Saidane O; Sahli H; Abdelmoula L; Zouari R
    Therapie; 2015; 70(3):311-2. PubMed ID: 25997838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
    Sendur OF; Turan Y; Berkit IK; Tastaban E
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
    Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.